Alvogen Korea Overview
- Year Founded
-
1958
- Status
-
Acquired/Merged
- Employees
-
605
- Latest Deal Type
-
Corporate
- Financing Rounds
-
3
Alvogen Korea General Information
Description
Manufacturer of pharmaceutical products based in Seoul, South Korea. The company offers treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology, thereby ensuring affordable generic medications that help reduce healthcare costs around the world.
Contact Information
Website
www.alvogenkorea.com(Operating Subsidiary)
Corporate Office
- 5th floor
- GT Tower, 411 Seocho-daero
- Seoul, Seocho-gu 06615
- South Korea
Corporate Office
- 5th floor
- GT Tower, 411 Seocho-daero
- Seoul, Seocho-gu 06615
- South Korea
Alvogen Korea Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Alvogen Korea Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alvogen Korea Patents
Alvogen Korea Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3090744-A1 | Pharmaceutical complex formulation comprising angiotensin ii receptor blocker and hmg-coa reductase inhibitor | Active | 30-Dec-2013 | ||
| EP-3090744-A4 | Pharmaceutical complex formulation comprising angiotensin ii receptor blocker and hmg-coa reductase inhibitor | Active | 30-Dec-2013 | ||
| EP-3090744-B1 | Pharmaceutical complex formulation comprising angiotensin ii receptor blocker and hmg-coa reductase inhibitor | Active | 30-Dec-2013 | ||
| EP-3085364-A4 | Pharmaceutical combined preparation containing hmg-coa reductase inhibitor and cholesterol absorption inhibitor | Inactive | 18-Dec-2013 | ||
| EP-3085364-A1 | Pharmaceutical combined preparation containing hmg-coa reductase inhibitor and cholesterol absorption inhibitor | Inactive | 18-Dec-2013 | A61K9/28 |
Alvogen Korea Executive Team (8)
| Name | Title | Board Seat |
|---|---|---|
| Joon-Soo Lee | Co-Chief Executive Officer & Board Member | |
| Lee Jun-Soo | Chief Executive Officer | |
| Joo-Hyung Lee | Co-Chief Executive Officer | |
| Shekar Poojari | Chief Financial Officer | |
| Kristjansson Thor | Executive Vice President of Strategic Projects and M&A |
Alvogen Korea Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Self | Board Member | ||
| Alvogen Korea | Chairman | ||
| Alvogen Korea | Co-Chief Executive Officer & Board Member | ||
| Alvogen Group | Board Member | ||
| Self | Board Member |
Alvogen Korea Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alvogen Korea FAQs
-
When was Alvogen Korea founded?
Alvogen Korea was founded in 1958.
-
Who is the CEO of Alvogen Korea?
Joon-Soo Lee, Lee Jun-Soo, and Joo-Hyung Lee are the CEOs of Alvogen Korea.
-
Where is Alvogen Korea headquartered?
Alvogen Korea is headquartered in Seoul, South Korea.
-
What is the size of Alvogen Korea?
Alvogen Korea has 605 total employees.
-
What industry is Alvogen Korea in?
Alvogen Korea’s primary industry is Pharmaceuticals.
-
Is Alvogen Korea a private or public company?
Alvogen Korea is a Private company.
-
What is Alvogen Korea’s current revenue?
The current revenue for Alvogen Korea is .
-
When was Alvogen Korea acquired?
Alvogen Korea was acquired on 15-Feb-2019.
-
Who acquired Alvogen Korea?
Alvogen Korea was acquired by Alvogen Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
